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The Hippo-YAP pathway regulates organ size by modulating cell proliferation and apoptosis.
Yu et al. now reveal that G-protein-coupled receptors act upstream of the transcriptional coactiva-
tors YAP/TAZ. This study reinforces the connection between the actin cytoskeleton and Hippo
pathway activity and identifies a class of secreted extracellular regulators of YAP/TAZ activity.The Hippo pathway has major roles in
the modulation of cell proliferation, apo-
ptosis, migration, and differentiation. It is
essential both during developmental
growth and in maintaining homeostasis
of adult organs, and when deregulated it
can cause tumorigenesis (Pan, 2010).
The first description of the pathway
came from the discovery of connections
between the Drosophila tumor sup-
pressors Hippo, Salvador, and Warts.
Subsequent studies have identified an
ever-increasing number of pathway com-
ponents and firmly established its im-
portance as a conserved regulator of
organ growth. The core of the Hippo
pathway comprises two Ser/Thr kinases,
Hippo (Mst1/2 in mammals) and Warts
(Lats1/2 in mammals), which act sequen-
tially, with Mst1/2 responsible for acti-
vating Lats1/2. Under nonproliferating
conditions, this module represses growth
by phosphorylating the homologous
transcriptional coactivators YAP and
TAZ, leading to their retention in the cyto-
plasm and to their degradation. When
YAP/TAZ are not phosphorylated by LATS
kinases, they accumulate in the nucleus,
where they associate with DNA-binding
proteins such as TEAD, leading to the
expression of genes that promote cell
proliferation (Pan, 2010; Staley and Irvine,
2012).
Central to understanding the role of this
pathway is elucidation of the mechanisms
that regulate theactivity of theMST-LATS-
YAP core. Several different upstream
regulators have been described, involving
diverse molecules, but common features
have emerged: Hippo signaling is regu-
lated by cell contact and cell polarity,
and proteins identified as upstream regu-lators have generally been proteins asso-
ciated with cell junctions.
The work from Yu et al. (2012) pre-
sented in this issue identifies a new class
of Hippo pathway regulators. Their dis-
covery stems from an elegant biochem-
ical characterization of the influence of
serum on Yap activity in cultured cells,
which reveals that phospholipids present
in serum, lysophosphatidic acid (LPA),
and sphingosine 1-phosphophate (S1P)
could elevate YAP/TAZ activity. They
showthat thesephospholipidsact through
G-protein-coupled receptors (GPCRs).
GPCRs comprise a large family of cell-
surfacemolecules involved in signal trans-
duction, and while the action of LPA and
S1P is specifically related to GPCRs that
act through the G proteins G12 and G13,
Yu et al. show that a wide range of
G proteins can potentially influence LATS
activity, with Gi class G proteins activating
LATS and thereby repressing YAP/TAZ,
whereas Gs class G proteins inhibit LATS
and thereby activate YAP/TAZ.
GPCRs comprise the largest family of
cell-surface molecules involved in sig-
nal transmission (Dorsam and Gutkind,
2007). Given the enormous number of
GPCRs and their agonists, the Yu et al.
study raises the possibility that a wide
range of secreted signals could modulate
growth through theHippo pathway.More-
over, they provide evidence that some
functions previously ascribed to G protein
signaling, such as effects of LPA on cell
migration and cell proliferation, could be
mediated through YAP/TAZ. Thus, de-
pending on the cell environment, hor-
mones, developmental stage, and, of
course, the localization and expression
of GPCRs, a multitude of possible effectsCell 15on cells involving GPCR-Hippo pathway
connections needs to be considered.
More studies are needed to evaluate the
significance of the GPCR-Hippo connec-
tion to normal development and physi-
ology, but Yu et al. provide some hints
by documenting effects of other GPCR
ligands, such as epinephrine and glu-
cagon, on YAP/TAZ phosphorylation. It
will also be important to investigate
whether YAP/TAZ activation contributes
to the many cancers in which GPCRs
are overexpressed or activated.
Although the discovery of G protein
regulation of Hippo signaling is unantici-
pated, recent discoveries of how the
F-actin cytoskeleton and mechanical ten-
sion influence YAP/TAZ activity provides
a basis for beginning to understanding
how G protein activity is linked to regula-
tion of YAP/TAZ (Figure 1). Studies first
in Drosophila and subsequently in cul-
tured mammalian cells reveal that dis-
ruption of genes that limit F-actin poly-
merization lead to activation of YAP/TAZ
or its Drosophila homolog, Yorkie, evi-
dently through inhibition of LATS/Warts
(Ferna´ndez et al., 2011; Sansores-Garcia
et al., 2011). F-actin is also implicated
in LATS regulation by cell attachment
(Zhao et al., 2012) or altered cell mor-
phology (Wada et al., 2011). Meanwhile,
variations in cytoskeletal tension, such
as what cells experience when cultured
on substrates of different elasticities,
modulate YAP/TAZ activity through an
unknown mechanism that appears inde-
pendent of Hippo signaling but depends
upon theGTPaseRho,which is a regulator
of actin polymerization and ROCK/Myosin
activity (Dupont et al., 2011). More-
over, although MST1/2 is predominantly0, August 17, 2012 ª2012 Elsevier Inc. 669
Figure 1. GPCRs and Other Upstream Regulators of the Hippo Signaling Pathway
A schematic of the Hippo signaling pathway is depicted (for simplification, many components have been
omitted). Modulation of F-actin dynamics is essential for the regulation of YAP/TAZ by several upstream
pathways. Binding of extracellular ligands of GPCRs, or cell attachment, stimulates the Hippo signaling
pathway positively or negatively through Lats1/2 by an unknown mechanism that requires Rho and
F-actin. Conversely, mechanical cues seem to act independently of Lats1/2 to trigger the activation of
YAP/TAZ. Cell-cell contact, which can be mediated by a number of junctional complexes, including
Merlin-containing complexes, can inhibit YAP through MST/LATS. Other junctional complexes (not
shown) can act independently of MST.cytoplasmic, a small proportion is associ-
ated with the actin cytoskeleton and can
be activated by actin disruption (Den-
sham et al., 2009). Yu et al. find that
G12/13 regulation of YAP/TAZ is depen-
dent upon both Rho and F-actin and in-
dependent of MST and ROCK. Thus,
although some aspects of these studies
appear in conflict (such as whether Rho-
dependent modulation of YAP/TAZ is
dependent upon LATS), overall, they sug-
gest that YAP/TAZ activity can be modu-670 Cell 150, August 17, 2012 ª2012 Elsevielated by a wide range of processes that
impinge upon F-actin organization, in-
cluding GPCRs. They also imply that the
balance between modulators of actin
structures will be crucial for the final
cellular response through YAP/TAZ. The
influence of serum on YAP/TAZ is mostly
transient, and the dynamic nature of these
pathways will also be an important con-
sideration for future investigations of
how GPCR effects are integrated with
other cytoskeletal modulators.r Inc.Nevertheless, the next step remains
elusive: what are the mechanisms by
which Rho or F-actin promote nuclear
localization of YAP/TAZ? Evidence sug-
gests that, depending upon the stimulus,
they may initiate a Lats-dependent or
Lats-independent cascade, but how are
they connected? The beginning of a pos-
sible hypothesis arises from the observa-
tion that some regulators of YAP/TAZ
or LATS also have the ability to bind actin
or to modulate actin organization, in-
cluding Zyxin, Expanded, NF2/Merlin,
and Ajuba. Changes in F-actin might
affect the localization or activity of these
proteins in some way, but mechanistic
studies are needed to solve this mystery.
With the rapid pace of progress in the
Hippo field, it may not be long before the
next series of studies will lead us to under-
stand the journey that begins with the
activation of receptors through the actin
filaments to the core of the Hippo
pathway and the regulation of YAP/TAZ.REFERENCES
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